Altimmune Inc (ALT) Implied Volatility Current

Tracking ALT implied volatility helps you identify when options premiums on Altimmune Inc are historically cheap or expensive, and where the best trades are hiding. Altimmune Inc implied volatility reflects the market's expectation of future price movement: when ALT IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Altimmune Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For ALT, tracking metrics like ALT IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on ALT signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc.

in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where ALT implied volatility sits today versus where it has been. Our scanner ranks Altimmune Inc implied volatility against its historical range, surfaces extremes in ALT IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Altimmune Inc IV is rich or cheap — measure it, then act on it.